Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Factor IX assays in treated hemophilia B patients].
Pouplard C, Jeanpierre E, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzallah I, Proulle V, Smahi M, Sobas F, Ternisien C, Toulon P, Voisin S, Nougier C; groupe d’études de la biologie des maladies hémorragiques du Groupe français d’études de l’hémostase et la thrombose. Pouplard C, et al. Among authors: jeanpierre e. Ann Biol Clin (Paris). 2019 Feb 1;77(1):41-52. doi: 10.1684/abc.2019.1414. Ann Biol Clin (Paris). 2019. PMID: 30799297 Free article. Review. French.
Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma.
Perrin J, Depasse F, Lecompte T; French-speaking CAT group and under the aegis of GEHT; French-speaking CAT group (all in France unless otherwise stated):; French-speaking CAT group all in France unless otherwise stated. Perrin J, et al. Thromb Res. 2015 Jul;136(1):125-30. doi: 10.1016/j.thromres.2014.12.015. Epub 2014 Dec 24. Thromb Res. 2015. PMID: 25563679
[Factor VIII assays in treated hemophilia A patients].
Lasne D, Pouplard C, Nougier C, Eschwege V, Le Cam Duchez V, Proulle V, Smahi M, Harzallah I, Voisin S, Toulon P, Sobas F, Galinat H, Flaujac C, Ternisien C, Jeanpierre E; groupe d'études de la biologie des maladies hémorragiques du Groupe français d'études de l'hémostase et la thrombose. Lasne D, et al. Among authors: jeanpierre e. Ann Biol Clin (Paris). 2019 Feb 1;77(1):53-65. doi: 10.1684/abc.2019.1413. Ann Biol Clin (Paris). 2019. PMID: 30799298 Free article. Review. French.
Multicentre evaluation of CK Prest® for assaying plasma levels of factor IX fused with albumin (Idelvion® ).
Pouplard C, Galinat H, Ternisien C, Blanc Jouvan F, De Maistre E, Duchemin J, Flaujac C, Hézard N, Grand F, Le Cam-Duchez V, Marlu R, Mourey G, Nedelec F, Pineau-Vincent F, Repesse Y, Stépanian A, Szymezak J, Voisin S, Voyer AL, Jeanpierre E, Lasne D; French Study Group on Laboratory Management of bleeding disorders (BIMHO group). Pouplard C, et al. Among authors: jeanpierre e. Haemophilia. 2019 Sep;25(5):e327-e330. doi: 10.1111/hae.13812. Epub 2019 Jul 11. Haemophilia. 2019. PMID: 31294887 No abstract available.
Multicentre pharmacokinetic evaluation of rFVIII-Fc (efmoroctocog alfa) in a real life and comparison with non-extended half-life FVIII concentrates.
Pouplard C, Sattler L, Ryman A, Eschwege V, De Maistre E, Flaujac C, Szymezak J, Grand F, Repesse Y, Galinat H, Donnard M, Ternisien C, Iorio A, Chelle P, Jeanpierre E; ‘Biology Study Group on Haemorrhagic Diseases’ (Group BIMHO - GFHT). Pouplard C, et al. Among authors: jeanpierre e. Haemophilia. 2020 Mar;26(2):282-289. doi: 10.1111/hae.13946. Epub 2020 Feb 27. Haemophilia. 2020. PMID: 32107819
Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
Jeanpierre E, Pouplard C, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzallah I, Proulle V, Smahi M, Sobas F, Stepina N, Toulon P, Voisin S, Ternisien C, Nougier C; French Study Group on the Biology of Hemorrhagic Diseases (the BIMHO group). Jeanpierre E, et al. Eur J Haematol. 2020 Aug;105(2):103-115. doi: 10.1111/ejh.13423. Epub 2020 May 27. Eur J Haematol. 2020. PMID: 32277501 Review.
Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals).
Nougier C, Jeanpierre E, Ternisien C, Proulle V, Hezard N, Pouplard C, Lasne D; With contributions from the Working Group on Biology of Haemorrhagic Disorders (BIMHO, Under the Aegis of GFHT). Nougier C, et al. Among authors: jeanpierre e. Eur J Haematol. 2020 Dec;105(6):675-681. doi: 10.1111/ejh.13490. Epub 2020 Sep 16. Eur J Haematol. 2020. PMID: 32668090 Review.
Impact of aPTT reagents on measurement of a PEGylated recombinant FVIII (Adynovi® /Adynovate® ): A French multicentric field assay study.
Ternisien C, Lasne D, Grand F, Harzallah I, Jeanpierre E, Repesse Y, Ryman A, Sapin AF, Voisin S, Nougier C, Pouplard C; French study group on laboratory management of bleeding disorders (BIMHO Group-GFHT). Ternisien C, et al. Among authors: jeanpierre e. Int J Lab Hematol. 2022 Apr;44(2):e55-e59. doi: 10.1111/ijlh.13707. Epub 2021 Sep 24. Int J Lab Hematol. 2022. PMID: 34559452 No abstract available.
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD.
Kizlik-Masson C, Peyron I, Gangnard S, Le Goff G, Lenoir SM, Damodaran S, Clavel M, Roullet S, Regnault V, Rauch A, Vincent F, Jeanpierre E, Dupont A, Ternisien C, Donnet T, Christophe OD, van Belle E, Denis CV, Casari C, Susen S, Lenting PJ. Kizlik-Masson C, et al. Among authors: jeanpierre e. Blood. 2023 Mar 23;141(12):1457-1468. doi: 10.1182/blood.2022017569. Blood. 2023. PMID: 36564031 Free article.
57 results